Thanatop : A novel 5-nitrofuran that is a highly active, cell-permeable inhibitor of topoisomerase IIPOLYCARPOU-SCHWARZ, Maria; MÜLLER, Kerstin; DENGER, Stefanie et al.Cancer research (Baltimore). 2007, Vol 67, Num 9, pp 4451-4458, issn 0008-5472, 8 p.Article

Anucleate cell blue assay : a useful tool for identifying novel type II topoisomerase inhibitorsOYAMADA, Yoshihiro; ITO, Hideaki; FUJIMOTO-NAKAMURA, Mika et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 1, pp 348-350, issn 0066-4804, 3 p.Article

Effect of topoisomerase II inhibitors on hyperthermic cytotoxicityWARTERS, R. L; BRIZGYS, L. M.Cancer research (Baltimore). 1988, Vol 48, Num 14, pp 3932-3938, issn 0008-5472Article

Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c]carbazoles as a new class of anti-cancer agentsPIERCE, Larry T; CAHILL, Michael M; WINFIELD, Hannah J et al.European journal of medicinal chemistry. 2012, Vol 56, pp 292-300, issn 0223-5234, 9 p.Article

Synthesis of friedelan triterpenoid analogs with DNA topoisomerase IIα inhibitory activity and their molecular docking studiesMANDAL, Amitava; GHOSH, Shilpi; ASHIM KUMAR BOTHRA et al.European journal of medicinal chemistry. 2012, Vol 54, pp 137-143, issn 0223-5234, 7 p.Article

Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIβMARCHION, Douglas C; BICAKU, Elona; TURNER, Joel G et al.Clinical cancer research. 2005, Vol 11, Num 23, pp 8467-8475, issn 1078-0432, 9 p.Article

First synthesis and anticancer activity of novel naphthoquinone amidesPRADIDPHOL, Narathip; KONGKATHIP, Ngampong; SITTIKUL, Pichamon et al.European journal of medicinal chemistry. 2012, Vol 49, pp 253-270, issn 0223-5234, 18 p.Article

NBTI 5463 Is a Novel Bacterial Type II Topoisomerase Inhibitor with Activity against Gram-Negative Bacteria and In Vivo EfficacyDOUGHERTY, Thomas J; NAYAR, Asha; NEWMAN, Joseph V et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 5, pp 2657-2664, issn 0066-4804, 8 p.Article

Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cellsMAMIDIPUDI, Vidya; TAO SHI; BRADY, Helen et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 4, pp 965-976, issn 0344-5704, 12 p.Article

Antiviral activity of topoisomerase II catalytic inhibitors against Epstein-Barr virusTING WU; YAN WANG; YAN YUAN et al.Antiviral research. 2014, Vol 107, pp 95-101, issn 0166-3542, 7 p.Article

In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole classMANI, Nagraj; GROSS, Christian H; GROSSMAN, Trudy H et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1228-1237, issn 0066-4804, 10 p.Article

DNA strand breaks induced by the anti-topoisomerase II bis-dioxopiperazine ICRF-193HAJJI, N; PASTOR, N; MATEOS, S et al.Mutation research. Fundamental and molecular mechanisms of mutagenesis. 2003, Vol 530, Num 1-2, pp 35-46, issn 1386-1964, 12 p.Article

Dihydroxylated 2,4,6-triphenyl pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure—activity relationship studyKARKI, Radha; THAPA, Pritam; KWON, Youngjoo et al.European journal of medicinal chemistry. 2012, Vol 49, pp 219-228, issn 0223-5234, 10 p.Article

Antitumor AZA-anthrapyrazoles: biophysical and biochemical studies on 8- and 9-aza regioisomersSISSI, Claudia; LEO, Elisabetta; MORO, Stefano et al.Biochemical pharmacology. 2004, Vol 67, Num 4, pp 631-642, issn 0006-2952, 12 p.Article

Inhibition of topoisomerase II α activity and induction of apoptosis in mammalian cells by semi-synthetic andrographolide analoguesNATEEWATTANA, Jintapat; SAEENG, Rungnapha; KASEMSOOK, Sakkasem et al.Investigational new drugs. 2013, Vol 31, Num 2, pp 320-332, issn 0167-6997, 13 p.Article

Sodium salicylate is a novel catalytic inhibitor of human DNA topoisomerase II alphaBAU, Jason T; KURZ, Ebba U.Biochemical pharmacology. 2011, Vol 81, Num 3, pp 345-354, issn 0006-2952, 10 p.Article

The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicitySWIFT, Lonnie P; CUTTS, Suzanne M; NUDELMAN, Abraham et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 5, pp 739-749, issn 0344-5704, 11 p.Article

Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasomeVISPE, S; VANDENBERGHE, I; ROBIN, M et al.Biochemical pharmacology. 2007, Vol 73, Num 12, pp 1863-1872, issn 0006-2952, 10 p.Article

DNA interactions of 2-pyrrolinodoxorubicin, a distinctively more potent daunosamine-modified analogue of doxorubicinSTEPANKOVA, Jana; STUDENOVSKY, Martin; MALINA, Jaroslav et al.Biochemical pharmacology. 2011, Vol 82, Num 3, pp 227-235, issn 0006-2952, 9 p.Article

New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitorsLUNIEWSKI, Wojciech; WIETRZYK, Joanna; GODLEWSKA, Joanna et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 19, pp 6103-6107, issn 0960-894X, 5 p.Article

Cytotoxicity and Cellular Uptake of Doxorubicin and its Formamidine Derivatives in HL60 Sensitive and HL60/MX2 Resistant CellsKIK, Krzysztof; WASOWSKA-LUKAWSKA, Malgorzata; OSZCZAPOWICZ, Irena et al.Anticancer research. 2009, Vol 29, Num 4, pp 1429-1433, issn 0250-7005, 5 p.Article

Synthèse de dérivés de l'ellipticine : relation entre cytotoxicité et pouvoir antitumoral et interaction avec l'ADN topoisomérase IIMarx-Larrazabal, Maïté; Cros, Jean.1989, 157 p.Thesis

Tumor Cells Upregulate Normoxic HIF-1α in Response to DoxorubicinYITING CAO; EBLE, Joseph M; DEWHIRST, Mark W et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 20, pp 6230-6242, issn 0008-5472, 13 p.Article

Cardioprotective roles of aged garlic extract, grape seed proanthocyanidin, and hazelnut on doxorubicin-induced cardiotoxicityDEMIRKAYA, Erkan; AVCI, Aslihan; KESIK, Vural et al.Canadian journal of physiology and pharmacology. 2009, Vol 87, Num 8, pp 633-640, issn 0008-4212, 8 p.Article

Etude des mécanismes de résistance cellulaire sélectionnés in vitro sous l'action combinée de deux agents antitumoraux = In vitro study mechanisms of resistance selected by combinations of two antitumor drugsSoues, Sylvie; Charcosset, Jean-Yves.1992, 244 p.Thesis